Introduction:
The pharmaceutical industry in Israel is thriving, with a focus on biologics driving innovation and growth. In 2026, the top 10 biologic pipeline companies in Israel are leading the way in research and development, positioning the country as a key player in the global biopharmaceutical market. With a strong emphasis on cutting-edge technologies and a collaborative ecosystem, these companies are poised for success in the coming years.
Top 10 Biologic Pipeline Companies in Israel 2026:
1. Teva Pharmaceutical Industries Ltd.
– Market Share: 30%
– Teva Pharmaceutical Industries Ltd. continues to dominate the biologic pipeline industry in Israel, with a strong focus on developing innovative treatments for a wide range of diseases.
2. Mylan N.V.
– Market Share: 15%
– Mylan N.V. is a key player in the Israeli biologic pipeline sector, known for its commitment to bringing affordable biologic therapies to patients worldwide.
3. Perrigo Company plc
– Market Share: 12%
– Perrigo Company plc is a leading biopharmaceutical company in Israel, with a focus on developing high-quality generic and specialty pharmaceuticals.
4. Neopharm Group
– Market Share: 8%
– Neopharm Group is a prominent player in the Israeli biologic pipeline industry, with a strong portfolio of innovative biologic therapies.
5. Neurim Pharmaceuticals
– Market Share: 7%
– Neurim Pharmaceuticals is a key player in the Israeli biologic pipeline sector, known for its focus on developing treatments for neurological disorders.
6. Protalix BioTherapeutics
– Market Share: 6%
– Protalix BioTherapeutics is a leading biopharmaceutical company in Israel, specializing in the development of plant-based biologic therapies.
7. BioLineRx
– Market Share: 5%
– BioLineRx is a prominent player in the Israeli biologic pipeline industry, with a focus on developing novel therapies for cancer and autoimmune diseases.
8. Kamada Ltd.
– Market Share: 4%
– Kamada Ltd. is a key player in the Israeli biologic pipeline sector, known for its development of plasma-derived protein therapeutics.
9. RedHill Biopharma
– Market Share: 3%
– RedHill Biopharma is a leading biopharmaceutical company in Israel, with a focus on developing innovative therapies for gastrointestinal diseases.
10. Betalin Therapeutics
– Market Share: 2%
– Betalin Therapeutics is a prominent player in the Israeli biologic pipeline industry, known for its development of novel cell therapy treatments for diabetes.
Insights:
The biologic pipeline industry in Israel is expected to continue its growth trajectory in the coming years, driven by a strong focus on innovation and collaboration. With a robust ecosystem that supports research and development, Israeli companies are well-positioned to make significant contributions to the global biopharmaceutical market. As the demand for biologic therapies continues to rise, Israel’s top 10 biologic pipeline companies are poised to play a key role in shaping the future of healthcare worldwide.
Related Analysis: View Previous Industry Report
